GT
TBI

Glenmede Trust’s Trueblue TBI Stock Holding History

Glenmede Trust’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.3K Sell
12,525
-968
-7% -$5.39K ﹤0.01% 1412
2026
Q1 		$52.8K Buy
+13,493
New +$59.9K ﹤0.01% 1419
2020
Q4 		– Sell
-1,285
Closed -$19K – 2139
2020
Q3 		$19K Sell
1,285
-6
-0.5% -$93 ﹤0.01% 1645
2020
Q2 		$19K Buy
1,291
+612
+90% +$9.09K ﹤0.01% 1617
2020
Q1 		$16K Hold
679
– – ﹤0.01% 2202
2019
Q4 		$16K Buy
679
+192
+39% +$4.38K ﹤0.01% 2202
2019
Q3 		$10K Buy
487
+121
+33% +$2.5K ﹤0.01% 2361
2019
Q2 		$8K Hold
366
– – ﹤0.01% 2477
2019
Q1 		$8K Hold
366
– – ﹤0.01% 2462
2018
Q4 		$8K Buy
+366
New +$8.78K ﹤0.01% 2379
2018
Q2 		– Sell
-128
Closed -$3K – 2292
2018
Q1 		$3K Hold
128
– – ﹤0.01% 2532
2017
Q4 		$3K Hold
128
– – ﹤0.01% 2532
2017
Q3 		$2K Sell
128
-34,438
-100% -$779K ﹤0.01% 2596
2017
Q2 		$944K Hold
34,566
– – ﹤0.01% 778
2017
Q1 		$944K Buy
34,566
+128
+0.4% +$3.27K ﹤0.01% 778
2016
Q4 		$848K Hold
34,438
– – ﹤0.01% 782
2016
Q3 		$780K Buy
+34,438
New +$752K ﹤0.01% 803
2016
Q2 		– Sell
-18,018
Closed -$470K – 2698
2016
Q1 		$470K Sell
18,018
-480,350
-96% -$11.1M ﹤0.01% 935
2015
Q4 		$12.8M Sell
498,368
-91,811
-16% -$2.48M 0.09% 311
2015
Q3 		$13.3M Buy
590,179
+52,164
+10% +$1.34M 0.1% 301
2015
Q2 		$16.1M Buy
538,015
+30,712
+6% +$865K 0.12% 278
2015
Q1 		$12.4M Buy
507,303
+6,032
+1% +$136K 0.09% 323
2014
Q4 		$11.2M Buy
501,271
+122,396
+32% +$2.9M 0.09% 328
2014
Q3 		$9.57M Buy
378,875
+362,892
+2,270% +$10M 0.08% 314
2014
Q2 		$440K Hold
15,983
– – ﹤0.01% 912
2014
Q1 		$467K Hold
15,983
– – ﹤0.01% 883
2013
Q4 		$412K Buy
+15,983
New +$399K ﹤0.01% 908

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IH
IES Holdings Houston, Texas $311M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's TBI Position: Q2 2026 in Review

Glenmede Trust reduced its Trueblue (TBI) stake by 7.2% in Q2 2026, selling an estimated $5.39K and leaving 12,525 shares worth $87.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Glenmede Trust first reported a position in TBI in Q4 2013 and has held it in 27 quarters since. The position peaked at $16.1M in Q2 2015. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Glenmede Trust held 12,525 shares of Trueblue worth $87.3K as of Q2 2026.
  • Glenmede Trust sold 968 Trueblue shares in Q2 2026, an estimated $5.39K.
  • Trueblue made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1412 holding.
  • Glenmede Trust first reported a position in Trueblue in Q4 2013 and has held it in 27 quarters since.
  • Glenmede Trust's Trueblue position peaked at $16.1M in Q2 2015.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.